Competing causes of death for women with breast cancer and change over time from 1975 to 2003.
about
Understanding cardiovascular injury after treatment for cancer: an overview of current uses and future directions of cardiovascular magnetic resonanceThe effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancerA four-long non-coding RNA signature in predicting breast cancer survival.Weekly doxorubicin increases coronary arteriolar wall and adventitial thickness.Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical StudySurvival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital--a closer look into cause-specific mortality.Chronic statin administration may attenuate early anthracycline-associated declines in left ventricular ejection functionNovel treatment strategies for brain tumors and metastases.Preoperative delays in the US Medicare population with breast cancer.Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.Serious health events and discontinuation of routine cancer screening.MicroRNA-454 may function as an oncogene via targeting AKT in triple negative breast cancer.Association between age and survival in a cohort of Brazilian patients with operable breast cancer.Effect of age at diagnosis of breast cancer on the patterns and risk of mortality from all causes: a population-based study in Australia.Effects of treatment with chemotherapy and/or tamoxifen on the biomarkers of cardiac injury and oxidative stress in women with breast cancer.Death causes in breast cancer patients.Timing of Breast Cancer Surgery-How Much Does It Matter?Is guideline adherence the key to increased survival in patients with breast cancer?
P2860
Q26859193-18548AD3-6F23-41A2-B531-9302627B391FQ26999300-57539453-74E4-45ED-A94F-8D7A33A5C31BQ34346056-952AEA3C-B8FE-4E19-8913-CD0E5C61819BQ34600610-D6CE5D04-F032-45CF-8512-3ABB36673668Q34981443-4ADA7DF8-3E20-4A29-8145-307E62860AECQ34996470-5CF73F13-C713-46DB-8C95-31F556CFEE52Q35538919-28271EA1-9DA5-475B-884E-494E552C5F62Q35734471-F971EA82-B52B-4C1D-B1A4-936333DA058BQ36457171-BC6EE4BC-B2A0-4C60-8B30-ADE7F76F8866Q37100862-E68EA3DA-0FCD-4B2B-95F2-26759A0E5CE3Q37276259-96917AC0-7A02-4AB3-BADB-48530BD889D2Q37979769-353899DE-CBF2-4906-B63A-C1C02C4D6394Q41229122-4283C28D-FA08-44D9-8BC0-7C67C856DAA3Q41353024-1B7BC34A-D71C-4379-9EB0-56296657BF9EQ46030287-A7E6DFDE-4EAA-402E-A9FF-0EBBDD2032AAQ47131512-B62A50DE-8D26-48DF-89C4-D3D659007874Q48869594-60C22D99-22E3-4E7F-A372-ED797CCD4884Q50936037-F821BE3A-413D-4077-B252-416712B62274Q53082159-23DBB898-1EFF-4FA3-B13E-E6118DA526F5
P2860
Competing causes of death for women with breast cancer and change over time from 1975 to 2003.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Competing causes of death for ...... e over time from 1975 to 2003.
@en
type
label
Competing causes of death for ...... e over time from 1975 to 2003.
@en
prefLabel
Competing causes of death for ...... e over time from 1975 to 2003.
@en
P2093
P2860
P1476
Competing causes of death for ...... e over time from 1975 to 2003.
@en
P2093
Dejian Lai
Erin E Fox
Xianglin L Du
P2860
P304
P356
10.1097/COC.0B013E318142C865
P577
2008-04-01T00:00:00Z